pharmaceutical distributor
Scope
Date
~
-
Bio & Pharma
GC Biopharma inks $90mn deal for blood products in Brazil
South Korea's GC Biopharma Corp. on Monday announced on Monday that it has a supply contract with Blau Farmacêutica, a Brazilian pharmaceutica...
Jul 03, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s top pharmaceutical distributor buys 25% of No. 2 Baekje Pharma
South Korea’s top pharmaceutical distributor Geo-young Co. has acquired 25% of market No. 2 Baekje Pharmaceutical.Geo-young on Tuesday said th...
Jun 14, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics, Pfizer sign $411.3 mn agreement for long-term CDMO
Samsung Biologics Co., the world’s No. 1 contract drugmaker, announced a groundbreaking strategic partnership with Pfizer on Thursday, marking...
Jun 08, 2023 (Gmt+09:00)
-
Bio & Pharma
CrystalGenomics to supply anti-osteoarthritis drug to Russia for $2 mn
South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...
Jun 08, 2023 (Gmt+09:00)
-
Logistics
CJ OliveNetworks to build pharmaceutical distribution center
South Korean digital service company CJ OliveNetworks is accelerating its logistics center operations by teaming up with Pusan National University Y...
Jun 01, 2023 (Gmt+09:00)
-
Bio & Pharma
HanAll, Daewoong to develop Parkinson's treatment with US partner
South Korea's HanAll Biopharma Co. and Daewoong Pharmaceutical on Thursday said they concluded a contract with NurrOn Pharmaceuticals of the US on...
May 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare launches Remsima SC in Brazil
South Korean biopharmaceutical company Celltrion Healthcare Co. revealed on Monday its introduction of Remsima SC, a treatment for autoimmune diseas...
May 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong Pharmaceutical’s cumulative tech exports exceed $870 mn
South Korea’s Daewoong Pharmaceutical said on Friday that it had concluded three technology export agreements for new drugs and new drug candi...
May 12, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharmaceuticals gets marketing approval for epilepsy drug in Israel
South Korea’s SK Biopharmaceuticals said on Wednesday that the Israeli Ministry of Health has approved the company's new drug application (NDA...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Merck to build biopharma raw material plant in Korea
Global pharmaceutical company Merck is considering a plan to establish a biopharmaceutical raw material production facility in Daejeon.South Korean ...
May 03, 2023 (Gmt+09:00)
-
Bio & Pharma
Bionote, Covetrus sign distribution agreement diagnostic products for animals
BioNote, South Korean developer of diagnostic reagents for animals, announced on Tuesday that it has signed a supply contract with Covetrus, a US-ba...
Apr 25, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea’s KOTRA to aid domestic pharmaceutical firms in Japan entry
The government-run (South) Korea Trade-Investment Promotion Agency (KOTRA) announced on Tuesday that it will hold an export consultation meeting for...
Apr 18, 2023 (Gmt+09:00)
-
Bio & Pharma
JW Pharma to use zebrafish in new drug development
South Korean drug developer JW Pharmaceutical has entered into a memorandum of understanding (MOU) with Zefit, a domestic non-clinical trial institu...
Apr 10, 2023 (Gmt+09:00)
-
Bio & Pharma
Hugel names ex-CEO of LG Household & Health Care as chairman
South Korea's biopharmaceutical company Hugel Inc. on Friday said it appointed Cha Suk-yong, former CEO and vice chairman of LG Household & Heal...
Mar 31, 2023 (Gmt+09:00)
-
Bio & Pharma
CGBio inks export deal for hyaluronic acid fillers with Chinese distributor
CGBio, a South Korean bio-regenerative medical company, has signed an export deal with Shanghai Feiting Trading Co., a Chinese medical device distri...
Mar 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Boryung, Axiom Space to set up JV to explore space healthcare options
South Korea's Boryung Corp., just decades ago a mom-and-pop pharmacy, will bring its healthcare expertise to space with Axiom Space Inc., a US comme...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins $44 mn flu vaccine order from WHO agency
South Korea's pharmaceutical firm GC Biopharma Corp. said on Monday that it has won a $44.3 million (57.9 billion won) order for flu vaccines in a d...
Mar 21, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Plasma to build blood products plant in Indonesia
South Korea’s SK Plasma will build a blood products plant in Indonesia.Industry sources on Tuesday said the company recently received approval...
Mar 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea's Daewoong to export diabetes drug Envlo to Brazil, Mexico
South Korea’s Daewoong Pharmaceutical Co. said on Feb. 24 it is set to embark on global sales of Envlo, a new drug for diabetes, by exportin...
Feb 24, 2023 (Gmt+09:00)
-
Bio & Pharma
US calls on 2 S.Korean pharmaceutical companies for swift end to legal battle
Following its lawsuit against Daewoong Pharmaceutical, South Korea's Medytox Inc. is waging an all-out legal war against domestic counterpart Hugel ...
Feb 24, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Dongwon solo bidder for Boryung Biopharma estimated at $385 mn
South Korea’s leading seafood and logistics conglomerate Dongwon Group is seeking to buy local biopharmaceutical company Boryung Biopharma Co....
Feb 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Brazil approves Celltrion Pharm’s syringe facility
Celltrion Pharm Inc., a South Korean biopharmaceutical company, said on Monday it received certification from Brazil’s health regulator for it...
Feb 20, 2023 (Gmt+09:00)
-
Bio & Pharma
POSCO Int'l's pharmaceutical biz in Sudan attains No. 2 market ranking
A pharmaceutical company in Sudan set up by South Korea's POSCO International to find business opportunities in and make social contributions to the...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharm holds sales meeting for marketing Cenobamate in US
On Wednesday, SK Biopharmaceuticals Co. announced that its US subsidiary, SK Life Sciences Inc., held a "National Sales Meeting" in San Diego. The p...
Feb 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharmaceutical reports record-high revenue in 2022
South Korea's Hanmi Pharmaceutical Co. last year saw record-high performance thanks to its self-developed drugs, surpassing its previous best year o...
Feb 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Medytox to sell off 2.2 mn shares of Daewoong's American partner Evolus
Medytox Inc. said in a regulatory filing on Wednesday that it is selling off approximately 2.19 million shares of Evolus, Daewoong Pharmaceutical's ...
Feb 08, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong receives approval for its GERD drug Fexuclue in Ecuador
Daewoong Pharmaceutical said Friday that it has obtained marketing authorization from Ecuador's National Agency for Health Regulation, Control and S...
Feb 06, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea's Daewoong Pharmaceutical to export tech to British company
South Korea's Daewoong Pharmaceutical has licensed a new drug candidate for idiopathic pulmonary fibrosis (IPF) to CS Pharmaceuticals (CSP) of the U...
Feb 01, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korea, Japan compete in gastroesophageal reflux drug market
South Korea is battling Japan again, this time on the global market to treat gastroesophageal reflux disease (GERD). South Korea's pharmaceutical pr...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
DongKoo Bio signs MOU to move into SE Asian healthcare market
DongKoo Bio & Pharma Co. has built a bridgehead for expansion toward the world, including Southeast Asia by joining hands with LVMC Holdings, th...
Jan 26, 2023 (Gmt+09:00)
Latest News
- 1 US auto parts tariffs into force; Korea avoids heavy hit
- 2 NCSOFT invests in US game startup emptyvessel
- 3 Maybe Happy Ending: How a Seoul-made robot love story rewrote Broadway playbook
- 4 NPS yet to schedule external manager selection; PE firms’ fundraising woes deepen
- 5 Woori Financial wins approval for Tongyang, ABL Life acquisition